CEPT vs XRAY
Cantor Equity Partners II, Inc. (CEPT) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Cantor Equity Partners II, Inc. (CEPT) is a shell companies company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
CEPT does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
CEPT currently screens at market cap $0. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the CEPT and XRAY stock pages for the full models.
Not investment advice.